MedTrace Logo

Postoperative Periprosthetic Fractures in Hip Fracture Patients: Exeter vs Anatomic SP2 Lubinus Stem

NCT03326271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2527

Last updated 2019-10-24

No results posted yet for this study

Summary

Recent studies have indicated a high incidence of postoperative periprosthetic femoral fracture in elderly patients treated with two commonly used cemented polished, tapered femoral stems. The aim of this study was to compare the prevalence and incidence rate of PPF in a cohort of elderly with femoral neck fractures (FNF) treated with either a collarless, polished, tapered stem (Exeter) or an anatomic matte stem (Lubinus SP 2).

Patients and Methods In a multicentre retrospective cohort study 2529 patients 60 years and above, with a FNF as indication for primary surgery with a cemented hip arthroplasty were included. Patients were treated either with a polished tapered Exeter stem or a matte anatomic Lubinus SP12 stem according to the surgeons preference or to the praxis of the present department.

The incidence of perprosthetic femoral fractures Hip-related complications and repeat surgery were assessed at a minimum follow-up of 2 years postoperatively.

Conditions

  • Femoral Neck Fractures
  • Periprosthetic Fractures

Interventions

PROCEDURE

Exeter stem

Patients treated with an total or hemiarthroplasty using a Exeter stem for a displaced femoral neck fracture

PROCEDURE

Lubinus SP2 stem

Patients treated with an total or hemiarthroplasty using a SP2stem for a displaced femoral neck fracture

Sponsors & Collaborators

  • Sunderby Hospital

    collaborator OTHER

  • Karolinska Institutet

    collaborator OTHER

  • Sundsvall Hospital

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-04
Primary Completion
2017-04-01
Completion
2017-10-11

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03326271 on ClinicalTrials.gov